0 CHECKOUT

Research Report on China's Antidepressant Market, 2013-2017

  • ID: 2365618
  • December 2012
  • Region: China
  • 50 Pages
  • China Research & Intelligence

"Oct. 10 is ""World Mental Health Day"". In 2012, its theme is ""Depression: a Global Crisis"". According to statistics from the United Nations, about 350 million people suffer from depression in the world. Approximately one million people commit suicide every year because of depression. Depression becomes a health crisis worldwide.

Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom of depression caused by various reasons. It is a set of clinical syndrome or conditions centered by the depression of mood self-experience, which is characterized by chronicity, repeated outbreak and various symptoms such as depressed mood, sorrow and pain, lack of interest and pleasant sensation and no motivation. It is generally believed that the morbidity of depression is mainly associated with biochemical factors such as 5-HT, DA and NE, genetic factors as well as social and environmental factors.

In developed countries, the sales volume of medicines for depression and anxiety disorder amounts to 45% of market share of nervous centralis medicines. Depressant medicines and schizophrenia drugs totally account for 80% of world's mental disorder medicines. READ MORE >

Note: Product cover images may vary from those shown

1 Overview on Antidepressants
1.1 Current Clinical Application of Antidepressants
1.2 Monoamine Oxidase Inhibitors (MAOI)
1.3 Tricyclic Antidepressants (TCA)
1.4 Selective 5-HT Reuptake Inhibitors (SSRI)
1.4.1 Fluoxetine
1.4.2 Paroxetine
1.4.3 Setraline
1.4.4 Fluvoxamine
1.4.5 Citalopram
1.4.6 Escitalopram
1.5 NARI
1.5.1 Maprotiline
1.5.2 Reboxetine
1.5.3 Mianserine
1.6 SNRI
1.6.1 Venlafaxine
1.6.2 Trazodone
1.6.3 Nefazodone
1.6.4 Mirtazapine
1.6.5 Duloxetine
1.7 Plant Antidepressants
1.8 Others
1.8.1 Tianeptine
1.8.2 Deanxit
1.8.3 Loripram
1.8.4 S-aemesyl-methionine

2 Market Conditions of China's Antidepressants, 2011-2012
2.1 Market Size of Antidepressants in Hospital Medicines
2.2 Market Share of Antidepressants
2.3 Market Share of Major Antidepressant Manufacturers
2.4 Growth Rates of Major Antidepressant Varieties in Market

3 Analysis on Major Varieties of China's Antidepressants, 2011-2012
3.1 Fluoxetine
3.2 Venlafaxine
3.3 Sertraline
3.4 Citalopram
3.5 Mirtazapine
3.6 Fluvoxamine
3.7 Trazodone
3.8 Clomipramine
3.9 Duloxetine
3.10 Neurostan (Extract of St. John's Wort)

4 Reference Prices of China's Major Antidepressants, 2012

5 Prediction on Development of China's Antidepressants, 2013-2017
5.1 Prediction on Market Size
5.2 Technological Trends

Selected Charts
Chart Market Size of Global Antidepressants, 2007-2011
Chart Market Size of China's Antidepressants in Hospital Medicines, 2007-2012
Chart Market Shares of China's Major Antidepressant Varieties in Hospital Medicines, 2008-2011
Chart Market Shares of China's Fluoxetine Enterprises in Hospital Medicines, 2010-2011
Chart Market Size of China's Fluoxetine in Hospital Medicines, 2010-2011
Chart Market Shares of China's Venlafaxine Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of China's Sertraline Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of China's Citalopram Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of China's Mirtazapine Enterprises in Hospital Medicines, 2010-2011
Chart Prediction on Market Size of China's Antidepressants in Hospital Medicines, 2013-2017

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S